SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SANGUINE CORP. (SGNC) -- Ignore unavailable to you. Want to Upgrade?

To: Gwolf who wrote (2747)7/7/1998 8:43:00 PM
From: justaninvestor  Read Replies (2) | Respond to of 5402
 
Superb work guys at getting us this information. Now for the dumb question. You said "There are four stage that the product will have to go through to come to market: (1) animal safety (2) animal efficacy (3) human safety (4) human efficacy. In the safety phase they will inject the subjects with the solution to see if there are any adverse reactions. In the efficacy stage they will induce a condition such as a heart attack to see the reactions."

Does that mean that they literally induce a heart attack in a human being!? Can't be, can it?

bbruin "HLBS&DW"




To: Gwolf who wrote (2747)7/9/1998 1:19:00 AM
From: chirodoc  Read Replies (1) | Respond to of 5402
 
<<<<There are four stage that the product will have to go through to come to market: (1) animal safety (2) animal efficacy (3) human safety (4) human efficacy.

..and luckily we already know that it is safe in humans and animals. therefore, phases I and II should be a piece of cake.

curtis


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News